UBS initiated coverage of eHealth (EHTH) with a Neutral rating and $5.50 price target The company has executed well in improving core operations and improving cash flow over the past few years, the analyst tells investors in a research note. However, the firm says that with a more “volatile and uncertain environment ahead” as it relates to the Medicare Advantage space, it is difficult to have clear visibility into how the business will perform in the near term, given an expectation of elevated churn across the industry.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EHTH:
- eHealth price target lowered to $11 from $13 at RBC Capital
- eHealth price target raised to $7 from $5 at Craig-Hallum
- eHealth, Inc. Reports Mixed Q3 2024 Results
- Craig-Hallum says eHealth ‘beginning to hit its stride,’ upgrades to Buy
- eHealth upgraded to Buy from Hold at Craig-Hallum
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
